Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer

logo
Ajanta Pharma Ltd.
01 May 2025
2477.60
-1.22%
ICICI Securities Limited
Ajanta Pharma’s Q4FY25 result was in line with our expectations. Revenue growth of 11% YoY was primarily driven by India and US businesses while Africa institutional biz continues to be a drag (-54.1% YoY).
Ajanta Pharma Ltd. is trading at high day volume of 351.1K.
More from Ajanta Pharma Ltd.
Recommended